BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 26, 2008
View Archived Issues
Phynova announces collaboration agreement with Norgine in liver disease
Read More
Metabolon and Joslin Diabetes Center to collaborate in area of insulin resistance and diabetes
Read More
Hemispherx enters major contract with Lovelace Respiratory Research Institute
Read More
Zacharon completes Series A Financing to advance glycan inhibitor program
Read More
Infinity enters alliance with Purdue and Mundipharma for early clinical and discovery programs
Read More
Novel tachykinin NK1 receptor antagonists divulged in recent Merck & Co. patent
Read More
Recent GSK patent claims new 5-HT1A receptor antagonists for premature ejaculation
Read More
Novel therapeutic agents for cancer cachexia and muscle wasting imparted in recent Santhera patent
Read More
Neuromed completes enrollment for phase III trial of NMED-1077 in chronic low back pain
Read More
Biofrontera completes enrollment in phase II study of BF-derm1 in severe chronic urticaria
Read More
Cosmo and Dr. Falk sign licensing agreement for Rifamycin SV MMX
Read More
Avexa completes recruitment for first component of phase III trial of apricitabine
Read More
ChemDiv and Avineuro extend collaboration in Alzheimer's disease
Read More
Johnson & Johnson enter into definitive agreement to acquire Omrix
Read More
DepoMed enters into exclusive license agreement with Solvay for DM-1796
Read More
CHMP recommends refusal of Bristol-Myers' marketing authorization for Ixempra
Read More
CHMP recommends extension to Janssen-Cilag's marketing authorization for Prezista
Read More
Bristol-Myers exercises option to develop and commercialize Exelixis' XL-413
Read More
Medarex initiates phase Ib clinical trial of MDX-1106 in cancer
Read More
Antares and Population Council initiate phase II contraceptive ATD Gel trial
Read More
MK-677 does not meet efficacy endpoints in a phase II Alzheimer's disease study
Read More
UWA-0121 extends L-DOPA activity in primate model of Parkinson's disease
Read More
Hematide safe over the long term in chronic kidney disease patients
Read More
Antiallodynic activity of Adolor's novel potent NGF-TrkA antagonist
Read More
Preliminary phase II results show activity of GI-5005-containing therapy in HCV
Read More